Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial

DSpace Repository

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial

Author: Tomaschitz, Andreas; Verheyen, Nicolas; Meinitzer, Andreas; Pieske, Burkert; Belyavskiy, Evgeny; Brussee, Helmut; Haas, Josef; Maerz, Winfried; Pieske-Kraigher, Elisabeth; Verheyen, Sarah; Ofner-Ziegenfuss, Lisa; Hartaigh, Briain O.; Schwetz, Verena; Aberer, Felix; Grubler, Martin; Lang, Florian; Alesutan, Ioana; Voelkl, Jakob; Gaksch, Martin; Horina, Joerg H.; Dimai, Hans-Peter; Rus-Machan, Jutta; Stiegler, Claudia; Ritz, Eberhard; Fahrleitner-Pammer, Astrid; Pilz, Stefan
Tübinger Autor(en):
Lang, Florian
Alesutan, Ioana Simona
Völkl, Jakob Georg Jonathan
Published in: Journal of Hypertension (2016), Bd. 34, H. 7, S. 1347-1356
Verlagsangabe: Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1097/HJH.0000000000000927
ISSN: 1473-5598
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)